TrialJournal of hematology & oncology2016

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant.

Chen-Hua Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.